Department of Surgery

Medicine & Life Sciences

1. Latvia 100%
2. Neoplasms 52%
3. Parathyroid Neoplasms 48%
4. Thyroid Gland 44%
5. Adenoma 41%
6. Breast Neoplasms 40%
7. Primary Hyperparathyroidism 35%
8. Thyroid Nodule 29%
9. Fine Needle Biopsy 28%
10. University Hospitals 28%
11. Papillary Thyroid Cancer 28%
12. Colorectal Neoplasms 27%
13. Cadherins 23%
14. Acute Necrotizing Pancreatitis 22%
15. Laparoscopic Cholecystectomy 22%
16. Axilla 20%
17. Inflammation 20%
18. Population 20%
19. Mortality 19%
20. Hyperplasia 19%
21. Appendicitis 19%
22. Thyroid Neoplasms 19%
23. Needle Biopsy 18%
24. Debridement 17%
25. Glioblastoma 17%
26. Renal Cell Carcinoma 16%
27. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline 16%
28. Neck 16%
29. Pancreatic Neoplasms 16%
30. Cell Biology 16%
31. Neoplasm Metastasis 16%
32. Epithelial-Mesenchymal Transition 15%
33. Therapeutics 15%
34. Registries 15%
35. Stomach Neoplasms 15%
36. Brenner Tumor 14%
37. Survival 13%
38. Early Warning Score 13%
39. Gastro-enteropancreatic neuroendocrine tumor 13%
40. Incidence 13%
41. Drug Therapy 13%
42. Unilateral Breast Neoplasms 13%
43. Triple Negative Breast Neoplasms 13%
44. angiotensin converting enzyme 2 12%
45. Hemorrhoidectomy 12%
46. Neoplastic Stem Cells 12%
47. APC Genes 12%
48. Lignans 12%
49. Mutation 11%
50. Intraabdominal Infections 11%
51. Tigecycline 11%
52. Aztreonam 11%
53. Cancer Care Facilities 11%
54. Wounds and Injuries 11%
55. Pulmonary Valve 11%
56. Clinical Deterioration 10%
57. Pericarditis 10%
58. Aortic Coarctation 10%
59. Carcinoma 10%
60. Bile Ducts 10%
61. Ovarian Neoplasms 10%
62. Tibial Fractures 10%
63. Limb Salvage 10%
64. Adenomatous Polyposis Coli 10%
65. Parathyroid Glands 10%
66. Meropenem 10%
67. Nipples 10%
68. Arsenic 10%
69. Aortic Valve 10%
70. Goiter 10%
71. Mammaplasty 10%
72. Cholecystectomy 10%
73. Neoadjuvant Therapy 10%
74. Arteriovenous Fistula 9%
75. Contrast Media 9%
76. Adrenalectomy 9%
77. Segmental Mastectomy 9%
78. Varicose Veins 9%
79. Cystectomy 9%
80. Drainage 9%
81. Anal Canal 9%
82. Comorbidity 9%
83. Selenium 9%
84. Astrocytoma 9%
85. Hospital Departments 9%
86. Laparoscopy 9%
87. Vancomycin 9%
88. Ultrasonography 9%
89. Immunohistochemistry 9%
90. Tertiary Care Centers 9%
91. Genetic Markers 9%
92. Neutrophils 9%
93. Diagnostic Imaging 8%
94. Differential Diagnosis 8%
95. Rectal Neoplasms 8%
96. Diabetes Mellitus 8%
97. Polyps 8%
98. Hospitalization 8%
99. Confidence Intervals 8%
100. Elasticity Imaging Techniques 8%